0.53
-0.06(-10.17%)
Currency In USD
Address
1025 Connecticut Avenue NW
Washington, DC 20036
United States of America
Phone
202-327-5422
Website
Sector
Healthcare
Industry
Biotechnology
Employees
3
First IPO Date
July 12, 2023
| Name | Title | Pay | Year Born |
| Dr. Geoffrey Stuart Dow | Chairman, Chief Executive Officer & President | 125,555 | 1974 |
| Mr. Tyrone Miller | Chief Financial Officer & Treasurer | 135,632 | 1975 |
| Dr. Bryan Smith | Chief Medical Officer | 0 | 1966 |
| Ms. Kristen Landon | Chief Commercial Officer | 0 | 1967 |
| Ms. Jennifer Herz | Director | 0 | N/A |
60 Degrees Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is based in Washington, District of Columbia.